Linking Epidemiology to Epigenomics-Where Are We Today?

Cancer Prevention Research

Volumn 3, Issue 12, 2010, Pages 1505-1508

  Ulrich, Cornelia M ^a,b   Grady, William M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

CANCER EPIDEMIOLOGY; CANCER PREVENTION; CARCINOGENESIS; DNA METHYLATION; EPIGENETICS; GENE MUTATION; HUMAN; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVIEW;

DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; HUMANS; NEOPLASMS;

EID: 78650401976     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-10-0298     Document Type: Review

References (35)

1. Esteller M. Epigenetics in cancer. N Engl J Med 2008;358:1148-59.
2. Toyota M, Issa JP. Epigenetic changes in solid and hematopoietic tumors. Seminars in Oncology 2005;32:521-531. (Pubitemid 41396429)
3. Weisenberger DJ, Siegmund KD, Campan M, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006;38:787-93.
4. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999;96:8681-6. (Pubitemid 29354851)
5. Fraga MF, Ballestar E, Paz MF, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 2005;102:10604-9.
6. Shen L, Ahuja N, Shen Y, et al. DNA methylation and environmental exposures in human hepatocellular carcinoma. J Natl Cancer Inst 2002;94:755-61. (Pubitemid 34567960)
7. Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer 2004;4:988-93.
8. Peters I, Vaske B, Albrecht K, Kuczyk MA, Jonas U, Serth J. Adiposity and age are statistically related to enhanced RASSF1A tumor suppressor gene promoter methylation in normal autopsy kidney tissue. Cancer Epidemiol Biomarkers Prev 2007;16:2526-32. (Pubitemid 351196306)
9. Belinsky SA, Palmisano WA, Gilliland FD, et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res 2002;62:2370-7.
10. Kim DH, Kim JS, Ji YI, et al. Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer. Cancer Res 2003;63:3743-6.
11. Marsit CJ, Kim DH, Liu M, et al. Hypermethylation of RASSF1A and BLU tumor suppressor genes in non-small cell lung cancer for tobacco smoking during adolescence. Int J Cancer 2005;114:219-23.
12. Belinsky SA, Klinge DM, Liechty KC, et al. Plutonium targets the p16 gene for inactivation by promoter hypermethylation in human lung adenocarcinoma. Carcinogenesis 2004;25:1063-7.
13. Waterland RA, Jirtle RL. Transposable elements for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003;23:5293-300.
14. Pennisi E. Environmental epigenomics meeting: Supplements restore gene function via methylation. Science 2005;310:1761.
15. Ulrich CM. Folate and cancer prevention: where to next? Cancer Epidemiol Biomarkers Prev 2008;17:2226-30.
16. Kim YI Folate, colorectal carcinogenesis, and DNA from animal studies. Environ Mol Mutagen 2004;44:10-25.
17. Rampersaud GC, Kauwell GP, Hutson AD, Cerda JJ, Bailey LB. Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. American Journal of Clinical Nutrition 2000;72:998-1003.
18. Van Den Donk M, van Engeland M, Pellis L, et al. Dietary folate intake in combination with MTHFR C677T genotype and promoter methylation of tumor suppressor and DNA repair genes in sporadic colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2007;16:327-33.
19. Pufulete M, Al-Ghnaniem R, Khushal A, et al. Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma. Gut 2005;54:648-53.
20. Ulrich CM. Nutrigenetics in cancer research - folate metabolism and colorectal cancer. J Nutr 2005;135:2698-702.
21. Stern LL, Mason JB, Selhub J, Choi SW. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol, Biomarkers Prev 2000;9:849-53. (Pubitemid 30660060)
22. Shelnutt KP, Kauwell GP, Gregory JF, 3rd, et al. Methylenetetrahydrofolate reductase 677C->T polymorphism affects DNA methylation in response to controlled folate intake in young women. J Nutr Biochem 2004;15:554-60.
23. Jung AY, Poole EM, Bigler J, Whitton J, Potter JD, Ulrich CM. DNA methyltransferase and alcohol dehydrogenase: gene-nutrient interactions in relation to risk of colorectal polyps. Cancer Epidemiol Biomarkers Prev 2008;17:330-8. (Pubitemid 351272783)
24. Dolinoy DC, Huang D, Jirtle RL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci U S A 2007;104:13056-13061. (Pubitemid 351737592)
25. Curtin K, Slattery ML, Ulrich CM, et al. Genetic polymorphisms in one-carbon metabolism with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis 2007;28:1672-9.
26. Wallace K, Grau MV, Levine AJ, et al. Association between folate levels and CpG island hypermethylation in normal colorectal mucosa. Cancer Prev Res 2010;3:1552-64.
27. Ulrich CM. Folate and cancer prevention: a closer look at a complex picture. Am J Clin Nutr 2007;86:271-3.
28. Ulrich CM, Potter JD. Folate supplementation: Too much of a good thing? Cancer Epidemiol Biomarkers Prev 2006;15:189-93.
29. Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. Jama 2007;297:2351-9.
30. Mason JB Folate, cancer risk, and the Greek god, Proteus: a tale of two chameleons. Nutr Rev 2009;67:206-12.
31. Kim YI. Folic acid supplementation and cancer risk. Cancer Epidemiol Biomarkers Prev 2008;17:2220-25.
32. Ulrich CM, Potter JD. Folate and cancer - timing is everything. Jama 2007;297:2408-9.
33. Kim YI. Folate: a magic bullet or a double edged sword for colorectal cancer prevention?Gut 2006;55:1387-1389.
34. Figueiredo JC, Grau MV, Haile RW, et al. Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Nat Cancer Inst 2009;101:432-5.
35. Berman BP, Weisenberger DJ, Laird PW. Locking in on the human methylome. Nat Biotech 2009;27:341-342.